Peptide Based Cancer Therapeutics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

  • Published : Aug-2017
  • Tables : 150
  • Figures : 48
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT179MR
  • Format : ppt

Peptide based cancer therapeutics are yet to become widespread, but the initial low numbers certainly do not suggest any pessimism in the global market. With new developments in delivery, stability, modifications, and preclinical success, future growth potentials of such cancer therapeutics continue to intensify.  A slew of new peptides with positive preclinical results are entering into clinical trials that are focused on cancer treatment. Moreover, the application base of peptides is steadily expanding to other therapeutic areas as well. In the near future, the global peptide based cancer therapeutics market is likely to be influenced by the rising prevalence of cancer across the globe. WHO reveals that cancer is one of the leading causes of death worldwide, which accounted for more than 8 million deaths in 2015. Factor as such are expected to play an important role in boosting the popularity of peptide based cancer therapeutics further. In addition, various complications involved in conventional cancer therapeutics as well as the risk of sever side-effects are prompting medical professionals to utilise peptides in tumor and cancer treatment. Fact.MR’s latest report projects that the global peptide based cancer therapeutics market will surpass a valuation of US$ 11,160 Mn by 2022-end, expanding at an impressive CAGR of 9.2% during the forecast period (2017-2022).

Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. At present, there are a number of peptide based cancer therapeutics available in the market.  Incessant medical research on peptides has led to development of several peptide based cancer therapeutics that are showing greater results as compared to conventional cancer therapeutics.

Market Taxonomy

Drug

Distribution Channel

Goserelin

Hospital Pharmacies

Bortezomib

Retail Pharmacies

leuprorelin

Online Pharmacies

Others

 

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

North America To Lead The Global Peptide Based Cancer Therapeutics Market

In terms of revenues, North America is expected to dominate the global peptide based cancer therapeutics market in 2017 and beyond. The region’s potency in healthcare and a strong presence of various peptide based cancer therapeutic drug manufacturers is supporting the growth of the market in North America. During the forecast period, the market in the region is expected to surge at a robust CAGR.

On the basis of drugs, the bortezomib segment is expected to remain highly attractive throughout the assessment period. The segment currently accounts for around 40% revenue share of the global market. Between 2017 and 2022, the segment is expected to reflect a double-digit CAGR to reach a valuation is excess of US$ 4,725 Mn. It expected to grow at US$ 358.4 Mn annually over the course of the forecast period.

Competition Tracking

Fact.MR’s report has also profiled key companies that are operating in the global peptide based cancer Therapeutic market, which include AstraZeneca PLC, Allergan plc, Pfizer Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Abbott, AbbVie Inc., and Valeant Pharmaceuticals International, Inc.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

1. Global Peptide Based Cancer Therapeutics Market - Executive Summary

2. Global Peptide Based Cancer Therapeutics Market Overview
2.1. Introduction
       2.1.1. Global Peptide Based Cancer Therapeutics Market Taxonomy
       2.1.2. Global Peptide Based Cancer Therapeutics Market Definition
2.2. Global Peptide Based Cancer Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
       2.2.1. Global Peptide Based Cancer Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Cancer Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis 
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Peptide Based Cancer Therapeutics Market Analysis and Forecast By Drug 
3.1. Global Peptide Based Cancer Therapeutics Market Size and Forecast By Drug, 2012-2022
       3.1.1. Goserelin Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                3.1.1.2. Market Share Comparison, By Region
                3.1.1.3. Y-o-Y growth Comparison, By Region
       3.1.2. Bortezomib Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                3.1.2.2. Market Share Comparison, By Region
                3.1.2.3. Y-o-Y growth Comparison, By Region
       3.1.3. leuprorelin Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                3.1.3.2. Market Share Comparison, By Region
                3.1.3.3. Y-o-Y growth Comparison, By Region
       3.1.4. Others Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                3.1.4.1. Revenue (US$ Mn) Comparison, By Region
                3.1.4.2. Market Share Comparison, By Region
                3.1.4.3. Y-o-Y growth Comparison, By Region

4. Global Peptide Based Cancer Therapeutics Market Analysis and Forecast By Distribution Channel 
4.1. Global Peptide Based Cancer Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
       4.1.1. Hospital Pharmacies Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Retail Pharmacies Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Online Pharmacies Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region

5. Global Peptide Based Cancer Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       5.1.1. North America Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                5.1.1.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.2. Latin America Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                5.1.2.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.3. Europe Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                5.1.3.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.4. Japan Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                5.1.4.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.5. APEJ Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                5.1.5.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
       5.1.6. MEA Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
                5.1.6.1. Revenue (US$ Mn) Comparison, By Drug 
                5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

6. North America Peptide Based Cancer Therapeutics Market Analysis and Forecast, By Country, 2012-2022
6.1. US Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       6.1.1. Revenue (US$ Mn) Comparison, By Drug 
       6.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
6.2. Canada Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       6.2.1. Revenue (US$ Mn) Comparison, By Drug 
       6.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

7. Latin America Peptide Based Cancer Therapeutics Market Analysis and Forecast, By Country, 2012-2022
7.1. Brazil Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       7.1.1. Revenue (US$ Mn) Comparison, By Drug 
       7.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
7.2. Mexico Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       7.2.1. Revenue (US$ Mn) Comparison, By Drug 
       7.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
7.3. Argentina Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       7.3.1. Revenue (US$ Mn) Comparison, By Drug 
       7.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

8. Europe Peptide Based Cancer Therapeutics Market Analysis and Forecast, By Country, 2012-2022
8.1. Germany Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       8.1.1. Revenue (US$ Mn) Comparison, By Drug 
       8.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.2. UK Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       8.2.1. Revenue (US$ Mn) Comparison, By Drug 
       8.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.3. France Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       8.3.1. Revenue (US$ Mn) Comparison, By Drug 
       8.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.4. Spain Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       8.4.1. Revenue (US$ Mn) Comparison, By Drug 
       8.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.5. Italy Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       8.5.1. Revenue (US$ Mn) Comparison, By Drug 
       8.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.6. Nordic Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       8.6.1. Revenue (US$ Mn) Comparison, By Drug 
       8.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

9. Japan Peptide Based Cancer Therapeutics Market Analysis and Forecast, By Country, 2012-2022
9.1. Japan  Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       9.1.1. Revenue (US$ Mn) Comparison, By Drug 
       9.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

10. APEJ Peptide Based Cancer Therapeutics Market Analysis and Forecast, By Country, 2012-2022
10.1. China Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       10.1.1. Revenue (US$ Mn) Comparison, By Drug 
       10.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.2. India Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       10.2.1. Revenue (US$ Mn) Comparison, By Drug 
       10.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.3. Malaysia Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       10.3.1. Revenue (US$ Mn) Comparison, By Drug 
       10.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.4. Thailand Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       10.4.1. Revenue (US$ Mn) Comparison, By Drug 
       10.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.5. Singapore Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       10.5.1. Revenue (US$ Mn) Comparison, By Drug 
       10.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.6. Australia Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       10.6.1. Revenue (US$ Mn) Comparison, By Drug 
       10.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

11. MEA Peptide Based Cancer Therapeutics Market Analysis and Forecast, By Country, 2012-2022
11.1. GCC Countries Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       11.1.1. Revenue (US$ Mn) Comparison, By Drug 
       11.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.2. South Africa Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       11.2.1. Revenue (US$ Mn) Comparison, By Drug 
       11.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.3. Nigeria Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       11.3.1. Revenue (US$ Mn) Comparison, By Drug 
       11.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel 
11.4. Israel Peptide Based Cancer Therapeutics Market Size and Forecast, 2012-2022
       11.4.1. Revenue (US$ Mn) Comparison, By Drug 
       11.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel 

12. Global Peptide Based Cancer Therapeutics Market Competition Landscape and Company Profile
12.1. Company Share Analysis By Region
12.2. AstraZeneca plc
       12.2.1. Company Overview
       12.2.2. Peptide Based Cancer Therapeutics Market Drug list
       12.2.3. Peptide Based Cancer Therapeutics Market Drug Sales Data and Key Financials
       12.2.4. Key Developments
       12.2.5. SWOT Analysis
12.3. Allergan plc
       12.3.1. Company Overview
       12.3.2. Peptide Based Cancer Therapeutics Market Drug list
       12.3.3. Peptide Based Cancer Therapeutics Market Drug Sales Data and Key Financials
       12.3.4. Key Developments
       12.3.5. SWOT Analysis
12.4. Pfizer Inc
       12.4.1. Company Overview
       12.4.2. Peptide Based Cancer Therapeutics Market Drug list
       12.4.3. Peptide Based Cancer Therapeutics Market Drug Sales Data and Key Financials
       12.4.4. Key Developments
       12.4.5. SWOT Analysis
12.5. Takeda Pharmaceutical Company Limited
       12.5.1. Company Overview
       12.5.2. Peptide Based Cancer Therapeutics Market Drug list
       12.5.3. Peptide Based Cancer Therapeutics Market Drug Sales Data and Key Financials
       12.5.4. Key Developments
       12.5.5. SWOT Analysis
12.6. Johnson & Johnson
       12.6.1. Company Overview
       12.6.2. Peptide Based Cancer Therapeutics Market Drug list
       12.6.3. Peptide Based Cancer Therapeutics Market Drug Sales Data and Key Financials
       12.6.4. Key Developments
       12.6.5. SWOT Analysis
12.7. Abbott
       12.7.1. Company Overview
       12.7.2. Peptide Based Cancer Therapeutics Market Drug list
       12.7.3. Peptide Based Cancer Therapeutics Market Drug Sales Data and Key Financials
       12.7.4. Key Developments
       12.7.5. SWOT Analysis
12.8. AbbVie Inc
       12.8.1. Company Overview
       12.8.2. Peptide Based Cancer Therapeutics Market Drug list
       12.8.3. Peptide Based Cancer Therapeutics Market Drug Sales Data and Key Financials
       12.8.4. Key Developments
       12.8.5. SWOT Analysis
12.9. Valeant Pharmaceuticals International, Inc
       12.9.1. Company Overview
       12.9.2. Peptide Based Cancer Therapeutics Market Drug list
       12.9.3. Peptide Based Cancer Therapeutics Market Drug Sales Data and Key Financials
       12.9.4. Key Developments
       12.9.5. SWOT Analysis

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer

TABLE 1 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Goserelin Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Goserelin Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Goserelin Segment Market Share, By Region 2012-2016
TABLE 7 Global Goserelin Segment Market Share, By Region 2017-2022
TABLE 8 Global Goserelin Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Bortezomib Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Bortezomib Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Bortezomib Segment Market Share, By Region 2012-2016
TABLE 12 Global Bortezomib Segment Market Share, By Region 2017-2022
TABLE 13 Global Bortezomib Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global leuprorelin Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global leuprorelin Segment Value (US$ Mn), By Region 2017-2022
TABLE 16 Global leuprorelin Segment Market Share, By Region 2012-2016
TABLE 17 Global leuprorelin Segment Market Share, By Region 2017-2022
TABLE 18 Global leuprorelin Segment Y-o-Y, By Region 2015-2022
TABLE 19 Global Others Segment Value (US$ Mn), By Region 2012-2016
TABLE 20 Global Others Segment Value (US$ Mn), By Region 2017-2022
TABLE 21 Global Others Segment Market Share, By Region 2012-2016
TABLE 22 Global Others Segment Market Share, By Region 2017-2022
TABLE 23 Global Others Segment Y-o-Y, By Region 2015-2022
TABLE 24 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 25 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 26 Global Hospital Pharmacies Segment Market Share, By Region 2012-2016
TABLE 27 Global Hospital Pharmacies Segment Market Share, By Region 2017-2022
TABLE 28 Global Hospital Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 29 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 30 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 31 Global Retail Pharmacies Segment Market Share, By Region 2012-2016
TABLE 32 Global Retail Pharmacies Segment Market Share, By Region 2017-2022
TABLE 33 Global Retail Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 34 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 35 Global Online Pharmacies Segment Value (US$ Mn), By Region 2017-2022
TABLE 36 Global Online Pharmacies Segment Market Share, By Region 2012-2016
TABLE 37 Global Online Pharmacies Segment Market Share, By Region 2017-2022
TABLE 38 Global Online Pharmacies Segment Y-o-Y, By Region 2015-2022
TABLE 39 North America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 40 North America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 41 North America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 42 North America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 43 Latin America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 44 Latin America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 45 Latin America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 46 Latin America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 47 Europe Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 48 Europe Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 49 Europe Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 50 Europe Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 51 Japan Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 52 Japan Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 53 Japan Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 54 Japan Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 55 APEJ Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 56 APEJ Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 57 APEJ Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 58 APEJ Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 59 MEA Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 60 MEA Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 61 MEA Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 62 MEA Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 63 US Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 64 US Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 65 US Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 66 US Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 67 Canada Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 68 Canada Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 69 Canada Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 70 Canada Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 71 Brazil Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 72 Brazil Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 73 Brazil Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 74 Brazil Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 75 Mexico Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 76 Mexico Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 77 Mexico Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 78 Mexico Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 79 Argentina Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 80 Argentina Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 81 Argentina Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 82 Argentina Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 83 Germany Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 84 Germany Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 85 Germany Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 86 Germany Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 87 UK Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 88 UK Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 89 UK Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 90 UK Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 91 France Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 92 France Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 93 France Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 94 France Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 95 Spain Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 96 Spain Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 97 Spain Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 98 Spain Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 99 Italy Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 100 Italy Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 101 Italy Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 102 Italy Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 103 Nordic Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 104 Nordic Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 105 Nordic Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 106 Nordic Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 107 Japan  Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 108 Japan  Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 109 Japan  Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 110 Japan  Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 111 China Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 112 China Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 113 China Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 114 China Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 115 India Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 116 India Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 117 India Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 118 India Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 119 Malaysia Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 120 Malaysia Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 121 Malaysia Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 122 Malaysia Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 123 Thailand Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 124 Thailand Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 125 Thailand Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 126 Thailand Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 127 Singapore Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 128 Singapore Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 129 Singapore Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 130 Singapore Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 131 Australia Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 132 Australia Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 133 Australia Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 134 Australia Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 135 GCC Countries Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 136 GCC Countries Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 137 GCC Countries Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 138 GCC Countries Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 139 South Africa Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 140 South Africa Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 141 South Africa Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 142 South Africa Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 143 Nigeria Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 144 Nigeria Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 145 Nigeria Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 146 Nigeria Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
TABLE 147 Israel Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
TABLE 148 Israel Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
TABLE 149 Israel Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
TABLE 150 Israel Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022

FIG. 1 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Cancer Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Goserelin Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Goserelin Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Goserelin Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Bortezomib Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Bortezomib Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Bortezomib Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global leuprorelin Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global leuprorelin Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global leuprorelin Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 16 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 17 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 18 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 19 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 20 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 21 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 22 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 23 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 24 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 25 North America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 26 North America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 27 North America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 28 North America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 29 Latin America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 30 Latin America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 31 Latin America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 32 Latin America Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 33 Europe Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 34 Europe Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 35 Europe Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 36 Europe Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 37 Japan Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 38 Japan Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 39 Japan Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 40 Japan Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 41 APEJ Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 42 APEJ Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 43 APEJ Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 44 APEJ Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022
FIG. 45 MEA Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2012-2016
FIG. 46 MEA Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Drug 2017-2022
FIG. 47 MEA Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2012-2016
FIG. 48 MEA Peptide Based Cancer Therapeutics Market Value (US$ Mn), By Distribution Channel 2017-2022

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development